Alzamend Competitors
| ALZN Stock | USD 2.17 0.02 0.93% |
Alzamend Neuro vs Gilead Sciences Correlation
Very good diversification
The correlation between Alzamend Neuro and GILD is -0.23 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alzamend Neuro and GILD in the same portfolio, assuming nothing else is changed.
Moving against Alzamend Stock
| 0.5 | GANX | Gain Therapeutics | PairCorr |
| 0.48 | KOD | Kodiak Sciences | PairCorr |
| 0.41 | VRTX | Vertex Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.34 | VYNE | Vyne Therapeutics | PairCorr |
| 0.34 | XNCR | Xencor Inc | PairCorr |
Alzamend Neuro Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Alzamend Neuro and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Alzamend and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Alzamend Neuro does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Alzamend Stock performing well and Alzamend Neuro Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alzamend Neuro's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Cross Equities Net Income Analysis
Compare Alzamend Neuro and related stocks such as Novartis AG ADR, Pfizer Inc, and Sanofi ADR Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVS | 4.4 B | 8.9 B | 9.3 B | 9.2 B | 10.2 B | 17.8 B | 6.7 B | 7.7 B | 12.6 B | 11.7 B | 8.1 B | 24 B | 7 B | 14.8 B | 11.9 B | 13.7 B | 9.9 B |
| PFE | 579.7 M | 8.7 B | 9.8 B | 11.6 B | 9.1 B | 7 B | 7.2 B | 21.3 B | 11.2 B | 16.3 B | 9.2 B | 22.1 B | 31.4 B | 2.1 B | 8 B | 9.2 B | 7.8 B |
| SNY | 625 M | 5.6 B | 4.9 B | 3.7 B | 4.4 B | 4.3 B | 4.7 B | 8.4 B | 4.3 B | 2.8 B | 12.3 B | 6.2 B | 8.4 B | 5.4 B | 5.6 B | 7.8 B | 5 B |
| GILD | (4 M) | 2.8 B | 2.6 B | 3.1 B | 12.1 B | 18.1 B | 13.5 B | 4.6 B | 5.5 B | 5.4 B | 123 M | 6.2 B | 4.6 B | 5.7 B | 480 M | 552 M | 524.4 M |
Alzamend Neuro and related stocks such as Novartis AG ADR, Pfizer Inc, and Sanofi ADR Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Alzamend Neuro financial statement analysis. It represents the amount of money remaining after all of Alzamend Neuro operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Alzamend Neuro Competitive Analysis
The better you understand Alzamend Neuro competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Alzamend Neuro's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Alzamend Neuro's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Alzamend Neuro Competition Performance Charts
Five steps to successful analysis of Alzamend Neuro Competition
Alzamend Neuro's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Alzamend Neuro in relation to its competition. Alzamend Neuro's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Alzamend Neuro in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Alzamend Neuro's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Alzamend Neuro, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Alzamend Neuro position
In addition to having Alzamend Neuro in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Insurance Providers Thematic Idea Now
Insurance Providers
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Alzamend Neuro Correlation with its peers. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Will Biotechnology sector continue expanding? Could Alzamend diversify its offerings? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alzamend Neuro data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Alzamend Neuro's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alzamend Neuro represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Alzamend Neuro's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.